Werewolf Therapeutics, Inc. (HOWL) Executive Compensation
Werewolf Therapeutics, Inc. (HOWL) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: HOWL
CIK: 1785530
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerMichael Comeau
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-4 | 2026-09-22 | — | S-4 | 0001140361-26-037334 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-21 | — | SCHEDULE 13G Filing | 0001732748-26-000003 | View SEC Doc Filr Page |
| 425 | 2026-08-21 | — | 425 | 0001193125-26-360063 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-08-21 | 8-K | 0001193125-26-360059 | View SEC Doc Filr Page |
| 8-K | 2026-08-20 | 2026-08-14 | 8-K | 0001193125-26-359185 | View SEC Doc Filr Page |
| 10-Q | 2026-07-31 | 2026-06-30 | 10-Q | 0001785530-26-000019 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-31 | 8-K | 0001785530-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | 4 Filing | 0001134657-26-000020 | View SEC Doc Filr Page |
| 144 | 2026-07-06 | — | 144 Filing | 0001628280-26-047367 | View SEC Doc Filr Page |
| 144 | 2026-07-06 | — | 144 Filing | 0001628280-26-047366 | View SEC Doc Filr Page |
| 144 | 2026-07-06 | — | 144 Filing | 0001628280-26-047365 | View SEC Doc Filr Page |
| 144 | 2026-07-06 | — | 144 Filing | 0001628280-26-047364 | View SEC Doc Filr Page |
| 144 | 2026-07-06 | — | 144 Filing | 0001628280-26-047362 | View SEC Doc Filr Page |
| 144 | 2026-07-06 | — | 144 Filing | 0001628280-26-047360 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-02 | — | SCHEDULE 13D/A Filing | 0001346824-26-000187 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-29 | 4 Filing | 0001134657-26-000019 | View SEC Doc Filr Page |
| 144 | 2026-06-29 | — | 144 Filing | 0001628280-26-046087 | View SEC Doc Filr Page |
| 144 | 2026-06-29 | — | 144 Filing | 0001628280-26-046086 | View SEC Doc Filr Page |
| 144 | 2026-06-29 | — | 144 Filing | 0001628280-26-046085 | View SEC Doc Filr Page |
| 144 | 2026-06-29 | — | 144 Filing | 0001628280-26-046084 | View SEC Doc Filr Page |
| 144 | 2026-06-29 | — | 144 Filing | 0001628280-26-046083 | View SEC Doc Filr Page |
| 144 | 2026-06-29 | — | 144 Filing | 0001628280-26-046082 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-26 | — | SCHEDULE 13D/A Filing | 0001346824-26-000185 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-22 | — | SCHEDULE 13D/A Filing | 0001346824-26-000180 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 Filing | 0001231919-26-000688 | View SEC Doc Filr Page |